Characterization and Evaluation of Nano-niosomes Encapsulating Docetaxel against Human Breast, Pancreatic, and Pulmonary Adenocarcinoma Cancer Cell Lines

Background: Docetaxel (DXL) is an antineoplastic agent for cancer treatment, the therapeutic efficiency of which is limited due to low solubility, hydrophobicity, and tissue specificity.Objective: In this study, nano-niosomes were introduced for improving therapeutic index of DXL.Material and Method...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mohammadreza Ajdari, Aliyeh Ranjbar, Khashayar Karimian, Maryam Karimi, Hossein Heli, Naghmeh Sattarahmady
Format:	Artigo
Idioma:	Inglês
Publicat:	Shiraz University of Medical Sciences 2024-04-01
Col·lecció:	Journal of Biomedical Physics and Engineering
Matèries:	docetaxel taxane taxotere® niosome sorbitan monolaurate drug delivery systems
Accés en línia:	https://jbpe.sums.ac.ir/article_49905_c919399ba6fd9af9f792059b06ce4209.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!